101 related articles for article (PubMed ID: 16272714)
1. Quantitative evaluation of effect of renal failure on the pharmacokinetics of panipenem in rats.
Tajima N; Soma M; Ishizuka H; Naganuma H
Biol Pharm Bull; 2005 Nov; 28(11):2170-2. PubMed ID: 16272714
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal function.
Tajima N; Ishizuka H; Naganuma H
Chemotherapy; 2006; 52(5):245-53. PubMed ID: 16864999
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.
Ohashi N; Uematsu T; Nagashima S; Kanamaru M; Tajima N; Togawa A; Hishida A
J Infect Chemother; 2005 Feb; 11(1):24-31. PubMed ID: 15729484
[TBL] [Abstract][Full Text] [Related]
4. Variability in the renal clearance of cephalexin in experimental renal failure.
Maïza A; Daley-Yates PT
J Pharmacokinet Biopharm; 1993 Feb; 21(1):19-30. PubMed ID: 8410681
[TBL] [Abstract][Full Text] [Related]
5. Estimation of renal secretory function for organic cations by endogenous N1-methylnicotinamide in rats with experimental renal failure.
Shim CK; Sawada Y; Iga T; Hanano M
J Pharmacokinet Biopharm; 1984 Feb; 12(1):23-42. PubMed ID: 6235362
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of panipenem in neonates and retrospective evaluation of dosage.
Kimura T; Kokubun H; Nowatari M; Matsuura N; Sunakawa K; Kubo H
J Antimicrob Chemother; 2001 Jan; 47(1):51-9. PubMed ID: 11152431
[TBL] [Abstract][Full Text] [Related]
7. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
8. A rat model of early sepsis: relationships between gentamicin pharmacokinetics and systemic and renal effects of bacterial lipopolysaccharide combined with interleukin-2.
Studena S; Martinkova J; Slizova D; Krs O; Senkerik M; Springer D; Chládek J
Biol Pharm Bull; 2012; 35(10):1703-10. PubMed ID: 23037160
[TBL] [Abstract][Full Text] [Related]
9. Progressive renal insufficiency induces increasing protection against ischemic acute renal failure.
Zager RA; Baltes LA
J Lab Clin Med; 1984 Apr; 103(4):511-23. PubMed ID: 6699471
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats.
Kobayashi N; Maeda A; Horikoshi S; Shirato I; Tomino Y; Ise M
Nephron; 2002 Jul; 91(3):480-5. PubMed ID: 12119481
[TBL] [Abstract][Full Text] [Related]
11. Panipenem/betamipron.
Goa KL; Noble S
Drugs; 2003; 63(9):913-25; discussion 926. PubMed ID: 12678575
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
Thalhammer F; Hörl WH
Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
[TBL] [Abstract][Full Text] [Related]
13. Overview of a new carbapenem, panipenem/betamipron.
Shimada J; Kawahara Y
Drugs Exp Clin Res; 1994; 20(6):241-5. PubMed ID: 7758396
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction.
Okabe H; Hashimoto Y; Inui KI
J Pharm Pharmacol; 2000 Dec; 52(12):1467-72. PubMed ID: 11197074
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dexrazoxane in subjects with impaired kidney function.
Brier ME; Gaylor SK; McGovren JP; Glue P; Fang A; Aronoff GR
J Clin Pharmacol; 2011 May; 51(5):731-8. PubMed ID: 20484616
[TBL] [Abstract][Full Text] [Related]
16. Increased glomerular nitric oxide synthesis in gentamicin-induced renal failure.
Rivas-Cabañero L; Montero A; López-Novoa JM
Eur J Pharmacol; 1994 Jan; 270(1):119-21. PubMed ID: 8157077
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modeling of hepatocyte growth factor in experimental animals and humans.
Sugiura T; Takahashi S; Sano K; Abe T; Fukuta K; Adachi K; Nakamura T; Matsumoto K; Nakamichi N; Kato Y
J Pharm Sci; 2013 Jan; 102(1):237-49. PubMed ID: 23047829
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
Miettinen A; Stow JL; Mentone S; Farquhar MG
J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
[TBL] [Abstract][Full Text] [Related]
19. Disposition of quinine in rats with induced renal failure.
Onyeji CO; Dixon PA; Ugwu NC
Pharm Weekbl Sci; 1992 Aug; 14(4):185-90. PubMed ID: 1437497
[TBL] [Abstract][Full Text] [Related]
20. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
Lim AK; Mathanasenarajah G; Larmour I
Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
